OSE.PA Stock: OSE Immunotherapeutics S.A. Stock Price, Analysis & Insights
Get live OSE.PA stock price $3.89, comprehensive OSE Immunotherapeutics S.A. stock analysis, charts, news, and expert forecast. Real-time OSE.PA stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Based in Nantes, France, OSE Immunotherapeutics S.A. specializes in creating immunotherapies designed to activate or regulate the immune system. Their work primarily targets both immuno-oncology and autoimmune diseases. Their advanced pipeline featur...
Company Information
- CEO
- Marc Le Bozec
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 64
Contact Information
- Website
- https://www.ose-immuno.com
- Address
- 22, boulevard Benoni Goullin
- Country
- FR
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for OSE Immunotherapeutics S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for OSE Immunotherapeutics S.A.
- ⚠Investors should consider how OSE Immunotherapeutics S.A. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
88.07M
P/E Ratio (TTM)
-2.30
Beta
0.82
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare OSE.PA with peer companies:
- Price
- $2.72+1.69% (1D)
- Market cap
- 97.24M
- Price
- $4.28+3.73% (1D)
- Market cap
- 83.76M
- Price
- $1.93+2.88% (1D)
- Market cap
- 115.32M
- Price
- $2.76+0.29% (1D)
- Market cap
- 199.91M
- Price
- $4.80+2.13% (1D)
- Market cap
- 176.37M
- Price
- $0.26-6.64% (1D)
- Market cap
- 79.56M
- Price
- $9.26+4.99% (1D)
- Market cap
- 463.74M
- Price
- $1.56+0.77% (1D)
- Market cap
- 146.68M
- Price
- $2.94+3.89% (1D)
- Market cap
- 46.83M
- Price
- $0.77-0.13% (1D)
- Market cap
- 110.89M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
43/100 ⭐⭐⭐
- Overall
- -1.0%
- NYSE
- -1.6%
- NASDAQ
- -0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +1.3% | +1.9% | 19.8 | 83/100⭐⭐⭐⭐⭐ |
| Technology | +0.8% | +1.1% | +3.0% | 52.0 | 76/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.8% | +0.3% | +1.9% | 27.9 | 69/100⭐⭐⭐⭐ |
| Industrials | -0.3% | -0.9% | +2.7% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.8% | -1.3% | +0.4% | 21.9 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.6% | +1.6% | -2.5% | 31.2 | 44/100⭐⭐⭐ |
| Healthcare | -1.0% | -2.0% | +1.5% | 30.5 | 43/100⭐⭐⭐ |
| Real Estate | +0.5% | -1.1% | -0.0% | 50.0 | 33/100⭐⭐ |
| Energy | +0.5% | -3.6% | -0.0% | 35.9 | 31/100⭐⭐ |
| Utilities | +2.0% | -1.3% | -5.1% | 26.1 | 31/100⭐⭐ |
| Consumer Cyclical | -0.3% | +0.3% | -0.2% | 55.8 | 28/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.